Tarsus Pharmaceuticals, Inc. (TARS) › Net IncomeTarsus Pharmaceuticals, Inc. (TARS) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$1.32M2019: -$4.67M2020: -$26.81M2021: -$13.83M2022: -$62.09M2023: -$135.89M2024: -$115.55M2025: -$66.42M-$66.42M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$66.42M+42.5%2024-$115.55M+15.0%2023-$135.89M-118.9%2022-$62.09M-349.1%2021-$13.83M+48.4%2020-$26.81M-474.1%2019-$4.67M-254.1%2018-$1.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share